A Single Center study analysing transition from Pediatric to Adult Rheumatology
Latest Information Update: 01 Jul 2020
At a glance
- Drugs Adalimumab (Primary) ; Canakinumab (Primary) ; Colchicine (Primary) ; Cyclophosphamide (Primary) ; Etanercept (Primary) ; Mycophenolate mofetil (Primary) ; Prednisolone (Primary) ; Rituximab (Primary) ; Tocilizumab (Primary)
- Indications Behcet's syndrome; Familial Mediterranean fever; Juvenile rheumatoid arthritis; Spondylarthritis; Systemic lupus erythematosus
- Focus Therapeutic Use
- 01 Jul 2020 New trial record
- 06 Jun 2020 Results presented at the 21st Annual Congress of the European League Against Rheumatism